HIGH-RISK CANCER

Clinical trials for HIGH-RISK CANCER explained in plain language.

Never miss a new study

Get alerted when new HIGH-RISK CANCER trials appear

Sign up with your email to follow new studies for HIGH-RISK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

Powerful new cocktail aims to beat back aggressive rectal cancer

Disease control Not yet recruiting

This study tests whether adding a targeted therapy (cetuximab or bevacizumab) and an immunotherapy drug (PD-1 antibody) to standard short-course radiation and chemotherapy can better control high-risk rectal cancer that is not caused by certain gene faults. About 204 adults with …

Matched conditions: HIGH-RISK CANCER

Phase: PHASE3 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control

Last updated May 11, 2026 20:46 UTC

HIGH-RISK CANCER

Get alerted when new HIGH-RISK CANCER trials appear

Powerful new cocktail aims to beat back aggressive rectal cancer